CZENCritical Zone Exploration Network
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
"Preclinical and clinical studies completed in Italy and China show that CZEN 002 directly inhibits or kills Candida albicans, the major cause of all vaginal yeast infections," said James Lipton, Ph.D., chief scientific officer and director of Zengen.
A synthetic octapeptide, CZEN 002 was developed from more than 25 years of original research in the US, Europe and Asia on peptide molecules derived from alpha-Melanocyte-Stimulating Hormone (a-MSH).
In preclinical and clinical studies, CZEN 002 has been shown to directly kill pathological fungi, including Candida albicans, gram-negative and gram-positive bacteria, and to inhibit replication of HIV-1, the virus responsible for AIDS.